At its March meeting, EMA’s Management Board elected Rui Santos Ivo as new chair of the Board for a three-year period.
The Board adopted EMA’s annual report for 2024. Last year, the Agency issued its highest number of positive recommendations for new medicines in 15 years, delivering recommendations for 114 new medicines for human use. Among these, 46 had a new active substance. The Agency also recommended 25 veterinary medicines for marketing authorisation – the highest ever number of recommendations in a year.
